[go: up one dir, main page]

EA200300925A1 - Новый способ промышленного синтеза ранелата стронция и его гидратов - Google Patents

Новый способ промышленного синтеза ранелата стронция и его гидратов

Info

Publication number
EA200300925A1
EA200300925A1 EA200300925A EA200300925A EA200300925A1 EA 200300925 A1 EA200300925 A1 EA 200300925A1 EA 200300925 A EA200300925 A EA 200300925A EA 200300925 A EA200300925 A EA 200300925A EA 200300925 A1 EA200300925 A1 EA 200300925A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydrates
new method
industrial synthesis
strontium ranelate
ranelate
Prior art date
Application number
EA200300925A
Other languages
English (en)
Other versions
EA007489B1 (ru
Inventor
Люсиль Вэсс-Людо
Жан-Пьер Лекув
Паскаль Ланьлуа
Original Assignee
Ле Лаборатур Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатур Сервье filed Critical Ле Лаборатур Сервье
Publication of EA200300925A1 publication Critical patent/EA200300925A1/ru
Publication of EA007489B1 publication Critical patent/EA007489B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Inorganic Insulating Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Способ промышленного синтеза ранелата стронция формулы (I)и его гидратов.
EA200300925A 2002-09-24 2003-09-23 Способ промышленного синтеза ранелата стронция и его гидратов EA007489B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0211763A FR2844795B1 (fr) 2002-09-24 2002-09-24 Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates

Publications (2)

Publication Number Publication Date
EA200300925A1 true EA200300925A1 (ru) 2004-04-29
EA007489B1 EA007489B1 (ru) 2006-10-27

Family

ID=29415189

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300925A EA007489B1 (ru) 2002-09-24 2003-09-23 Способ промышленного синтеза ранелата стронция и его гидратов

Country Status (37)

Country Link
US (1) US7214805B2 (ru)
EP (1) EP1403266B1 (ru)
JP (1) JP4136867B2 (ru)
KR (1) KR100551501B1 (ru)
CN (1) CN1212321C (ru)
AP (1) AP1910A (ru)
AR (1) AR041355A1 (ru)
AU (2) AU2003248281B2 (ru)
BR (1) BR0304213A (ru)
CA (1) CA2442878C (ru)
CR (1) CR7764A (ru)
CY (1) CY1115162T1 (ru)
DK (1) DK1403266T3 (ru)
EA (1) EA007489B1 (ru)
EC (1) ECSP055741A (ru)
ES (1) ES2478620T3 (ru)
FR (1) FR2844795B1 (ru)
GE (1) GEP20074215B (ru)
HR (1) HRP20050359B1 (ru)
IL (1) IL167316A (ru)
IS (1) IS7807A (ru)
MA (1) MA26102A1 (ru)
ME (1) ME00455B (ru)
MX (1) MXPA03008643A (ru)
MY (1) MY134921A (ru)
NO (1) NO328638B1 (ru)
NZ (1) NZ528402A (ru)
OA (1) OA12934A (ru)
PL (1) PL214400B1 (ru)
PT (1) PT1403266E (ru)
RS (2) RS20050240A (ru)
SG (1) SG110071A1 (ru)
SI (1) SI1403266T1 (ru)
TN (1) TNSN05087A1 (ru)
UA (1) UA79156C2 (ru)
WO (1) WO2004029036A1 (ru)
ZA (1) ZA200307409B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1745791E (pt) * 2003-05-07 2013-07-23 Osteologix As Tratamento de afeções cartilagíneas/ósseas com sais de estrôncio hidrossolúveis
DE602004002832T2 (de) * 2003-05-07 2007-06-06 Osteologix A/S Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
AU2005216596B2 (en) 2004-02-26 2011-03-24 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
WO2005108339A2 (en) 2004-05-06 2005-11-17 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
KR20070034075A (ko) 2004-06-25 2007-03-27 스트론틴 에이피에스 스트론튬과 비타민 d를 함유하는 조성물 및 그의 용도
FR2875807B1 (fr) 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100538672C (zh) * 2005-04-18 2009-09-09 索尼株式会社 控制设备和方法
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
WO2007020527A2 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) * 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
WO2013013003A1 (en) 2011-07-21 2013-01-24 Emory University Methods for treating inflamatory conditions and states, and cancers by antagonizing nf-kb activation
CN102321068B (zh) * 2011-08-01 2013-01-23 山东铂源药业有限公司 一种雷奈酸锶的制备方法
WO2013175270A1 (en) * 2012-05-25 2013-11-28 Fleming Laboratories Limited Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate
ES2505716T3 (es) 2013-01-21 2015-09-04 Galenicum Health S.L. Composiciones farmacéuticas que comprenden una sal de ácido
CN103319454B (zh) * 2013-06-14 2014-06-18 广东众生药业股份有限公司 一种高纯度雷尼酸四乙酯及其中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates

Also Published As

Publication number Publication date
WO2004029036A1 (fr) 2004-04-08
PL214400B1 (pl) 2013-07-31
MA26102A1 (fr) 2004-04-01
AP1910A (en) 2008-10-30
HRP20050359A2 (en) 2005-06-30
AR041355A1 (es) 2005-05-11
UA79156C2 (en) 2007-05-25
IS7807A (is) 2005-04-19
KR100551501B1 (ko) 2006-02-13
DK1403266T3 (da) 2014-07-07
CA2442878C (fr) 2009-03-03
CN1212321C (zh) 2005-07-27
NO20034235D0 (no) 2003-09-23
NO328638B1 (no) 2010-04-12
FR2844795B1 (fr) 2004-10-22
MY134921A (en) 2008-01-31
FR2844795A1 (fr) 2004-03-26
ES2478620T3 (es) 2014-07-22
NO20034235L (no) 2004-03-25
JP2004149516A (ja) 2004-05-27
NZ528402A (en) 2004-07-30
GEP20074215B (en) 2007-10-10
SI1403266T1 (sl) 2014-06-30
US7214805B2 (en) 2007-05-08
JP4136867B2 (ja) 2008-08-20
CY1115162T1 (el) 2016-12-14
SG110071A1 (en) 2005-04-28
TNSN05087A1 (fr) 2007-05-14
AU2003282179A1 (en) 2004-04-19
HK1065791A1 (en) 2005-03-04
US20040063972A1 (en) 2004-04-01
AP2005003256A0 (en) 2005-03-31
PL362365A1 (en) 2004-04-05
ZA200307409B (en) 2004-07-07
RS20050240A (sr) 2007-06-04
KR20040026625A (ko) 2004-03-31
EP1403266B1 (fr) 2014-04-09
CA2442878A1 (fr) 2004-03-24
BR0304213A (pt) 2004-08-31
AU2003248281A1 (en) 2004-04-08
OA12934A (en) 2006-10-13
EA007489B1 (ru) 2006-10-27
RS53509B1 (sr) 2015-02-27
MXPA03008643A (es) 2005-04-19
CR7764A (es) 2005-10-06
ECSP055741A (es) 2005-07-06
HRP20050359B1 (hr) 2014-09-26
ME00455B (me) 2011-10-10
AU2003248281B2 (en) 2009-08-06
EP1403266A1 (fr) 2004-03-31
PT1403266E (pt) 2014-05-06
IL167316A (en) 2008-08-07
CN1496986A (zh) 2004-05-19

Similar Documents

Publication Publication Date Title
EA200300925A1 (ru) Новый способ промышленного синтеза ранелата стронция и его гидратов
CY1113362T1 (el) Διαρυλ-αιθερες, ως ανταγωνιστης οπιοειδους υποδοχεως
DE60335359D1 (de) Phthalazinonderivate
SE0000540D0 (sv) New compounds
EA200201057A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
DE60313625D1 (de) Metalloxyphthalocyaninverbindungen
ATE377004T1 (de) Proteinkinaseinhibitoren
ATE457025T1 (de) Kinaseinhibitoren
EA200801884A1 (ru) Новый способ синтеза ранелата стронция и его гидратов
EA200300927A1 (ru) Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
EA200300926A1 (ru) Новый способ промышленного синтеза метил дисложного эфира 5-амино-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
EA200600898A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
BR0214445A (pt) Processos para produzir compostos e composto
EA200600455A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600456A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600454A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600249A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600250A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU